deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT04238065

A Clinical Trial of Caterna Virtual Reality Facilitating Treatment in Children With Amblyopia (VRTA)

A Phase 3 Randomized, Single-blind, Multicenter, Clinical Control Study to Evaluate the Efficacy and Safety of Caterna Virtual Reality Facilitating Treatment Patients With Amblyopia in Children

Sponsor: Guangzhou Shijing Medical Software

Conditions Amblyopia
Interventions Caterna Virtual Reality Patch Spectacles(Best optical corrected distance vision)
Updated 6 times since 2020 Last updated: Feb 3, 2020 Started: Sep 4, 2019 Primary completion: Dec 31, 2020 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Amblyopia, this trial is ongoing. The trial is conducted by Guangzhou Shijing Medical Software and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshotRecruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotRecruiting~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotRecruiting~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2022 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Jan 2022 [monthly]

    Recruiting NA

  5. Mar 2020 — Jan 2021 [monthly]

    Recruiting NA

▶ Show 1 earlier version

  1. Feb 2020 — Mar 2020 [monthly]

    Recruiting NA

    First recorded

Sep 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Guangzhou Shijing Medical Software
  • The First Affiliated Hospital of Beijing University
  • The First Affiliated Hospital with Nanjing Medical University
  • Zhongshan Ophthalmic Center, Sun Yat-sen University
Data source: Guangzhou Shijing Medical Software

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations